ID HNRH3_HUMAN Reviewed; 346 AA. AC P31942; A8K682; B3KRE1; Q9BSX1; Q9NP53; Q9NP96; Q9NPA7; Q9NPI4; Q9UFU4; AC Q9Y4J5; DT 01-JUL-1993, integrated into UniProtKB/Swiss-Prot. DT 19-SEP-2002, sequence version 2. DT 02-DEC-2020, entry version 203. DE RecName: Full=Heterogeneous nuclear ribonucleoprotein H3; DE Short=hnRNP H3; DE AltName: Full=Heterogeneous nuclear ribonucleoprotein 2H9; DE Short=hnRNP 2H9; GN Name=HNRNPH3; Synonyms=HNRPH3; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND SUBCELLULAR LOCATION. RX PubMed=8999868; DOI=10.1074/jbc.272.3.1827; RA Mahe D., Mahl P., Gattoni R., Fischer N., Mattei M.-G., Stevenin J., RA Fuchs J.-P.; RT "Cloning of human 2H9 heterogeneous nuclear ribonucleoproteins. Relation RT with splicing and early heat shock-induced splicing arrest."; RL J. Biol. Chem. 272:1827-1836(1997). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1; 2; 3; 4; 5 AND 6). RX PubMed=10858537; DOI=10.1016/s0167-4781(00)00092-0; RA Honore B.; RT "The hnRNP 2H9 gene, which is involved in the splicing reaction, is a RT multiply spliced gene."; RL Biochim. Biophys. Acta 1492:108-119(2000). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 4). RC TISSUE=Brain, and Placenta; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4). RC TISSUE=Uterus; RX PubMed=17974005; DOI=10.1186/1471-2164-8-399; RA Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., RA Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., RA Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., RA Wiemann S., Schupp I.; RT "The full-ORF clone resource of the German cDNA consortium."; RL BMC Genomics 8:399-399(2007). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). RC TISSUE=Ovary, and Skin; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [7] RP PROTEIN SEQUENCE OF 1-6; 56-76; 85-90; 98-104; 175-200; 223-253 AND RP 262-323, ACETYLATION AT MET-1, METHYLATION AT ARG-287, AND IDENTIFICATION RP BY MASS SPECTROMETRY. RC TISSUE=Ovarian carcinoma; RA Bienvenut W.V., Lilla S., von Kriegsheim A., Lempens A., Kolch W.; RL Submitted (DEC-2008) to UniProtKB. RN [8] RP PROTEIN SEQUENCE OF 56-67; 206-222; 233-253 AND 262-287, AND IDENTIFICATION RP BY MASS SPECTROMETRY. RC TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex; RA Lubec G., Vishwanath V., Chen W.-Q., Sun Y.; RL Submitted (DEC-2008) to UniProtKB. RN [9] RP PROTEIN SEQUENCE OF 94-104 AND 288-298. RC TISSUE=Keratinocyte; RX PubMed=1286667; DOI=10.1002/elps.11501301199; RA Rasmussen H.H., van Damme J., Puype M., Gesser B., Celis J.E., RA Vandekerckhove J.; RT "Microsequences of 145 proteins recorded in the two-dimensional gel protein RT database of normal human epidermal keratinocytes."; RL Electrophoresis 13:960-969(1992). RN [10] RP PROTEIN SEQUENCE OF 116-127, AND METHYLATION AT ARG-121. RX PubMed=11152131; DOI=10.1110/ps.9.11.2210; RA Yague J., Vazquez J., Lopez de Castro J.A.; RT "A post-translational modification of nuclear proteins, N(G),N(G)-dimethyl- RT Arg, found in a natural HLA class I peptide ligand."; RL Protein Sci. 9:2210-2217(2000). RN [11] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=15592455; DOI=10.1038/nbt1046; RA Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H., RA Zha X.-M., Polakiewicz R.D., Comb M.J.; RT "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells."; RL Nat. Biotechnol. 23:94-101(2005). RN [12] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-216, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=17081983; DOI=10.1016/j.cell.2006.09.026; RA Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.; RT "Global, in vivo, and site-specific phosphorylation dynamics in signaling RT networks."; RL Cell 127:635-648(2006). RN [13] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-216, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007; RA Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., RA Greff Z., Keri G., Stemmann O., Mann M.; RT "Kinase-selective enrichment enables quantitative phosphoproteomics of the RT kinome across the cell cycle."; RL Mol. Cell 31:438-448(2008). RN [14] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-216, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=18669648; DOI=10.1073/pnas.0805139105; RA Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., RA Elledge S.J., Gygi S.P.; RT "A quantitative atlas of mitotic phosphorylation."; RL Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). RN [15] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-216, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200; RA Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G., RA Mann M., Daub H.; RT "Large-scale proteomics analysis of the human kinome."; RL Mol. Cell. Proteomics 8:1751-1764(2009). RN [16] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-216; SER-298 AND THR-314, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Leukemic T-cell; RX PubMed=19690332; DOI=10.1126/scisignal.2000007; RA Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., RA Rodionov V., Han D.K.; RT "Quantitative phosphoproteomic analysis of T cell receptor signaling RT reveals system-wide modulation of protein-protein interactions."; RL Sci. Signal. 2:RA46-RA46(2009). RN [17] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-216 AND SER-298, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=20068231; DOI=10.1126/scisignal.2000475; RA Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., RA Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.; RT "Quantitative phosphoproteomics reveals widespread full phosphorylation RT site occupancy during mitosis."; RL Sci. Signal. 3:RA3-RA3(2010). RN [18] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21269460; DOI=10.1186/1752-0509-5-17; RA Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., RA Bennett K.L., Superti-Furga G., Colinge J.; RT "Initial characterization of the human central proteome."; RL BMC Syst. Biol. 5:17-17(2011). RN [19] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-216 AND SER-298, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21406692; DOI=10.1126/scisignal.2001570; RA Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., RA Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.; RT "System-wide temporal characterization of the proteome and phosphoproteome RT of human embryonic stem cell differentiation."; RL Sci. Signal. 4:RS3-RS3(2011). RN [20] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-216; SER-298 AND THR-314, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma, and Erythroleukemia; RX PubMed=23186163; DOI=10.1021/pr300630k; RA Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J., RA Mohammed S.; RT "Toward a comprehensive characterization of a human cancer cell RT phosphoproteome."; RL J. Proteome Res. 12:260-271(2013). RN [21] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-216; TYR-296 AND SER-298, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Liver; RX PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014; RA Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L., RA Ye M., Zou H.; RT "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver RT phosphoproteome."; RL J. Proteomics 96:253-262(2014). RN [22] RP METHYLATION [LARGE SCALE ANALYSIS] AT ARG-174; ARG-323 AND ARG-343, RP METHYLATION [LARGE SCALE ANALYSIS] AT ARG-116; ARG-121 AND ARG-129 (ISOFORM RP 2), AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Colon carcinoma; RX PubMed=24129315; DOI=10.1074/mcp.o113.027870; RA Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M., RA Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V., RA Bedford M.T., Comb M.J.; RT "Immunoaffinity enrichment and mass spectrometry analysis of protein RT methylation."; RL Mol. Cell. Proteomics 13:372-387(2014). RN [23] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=25944712; DOI=10.1002/pmic.201400617; RA Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D., RA Lane L., Bairoch A., Van Dorsselaer A., Carapito C.; RT "N-terminome analysis of the human mitochondrial proteome."; RL Proteomics 15:2519-2524(2015). RN [24] RP SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-6 AND LYS-67, AND IDENTIFICATION RP BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=28112733; DOI=10.1038/nsmb.3366; RA Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C., RA Nielsen M.L.; RT "Site-specific mapping of the human SUMO proteome reveals co-modification RT with phosphorylation."; RL Nat. Struct. Mol. Biol. 24:325-336(2017). CC -!- FUNCTION: Involved in the splicing process and participates in early CC heat shock-induced splicing arrest. Due to their great structural CC variations the different isoforms may possess different functions in CC the splicing reaction. CC -!- INTERACTION: CC P31942; P09651: HNRNPA1; NbExp=3; IntAct=EBI-711437, EBI-352662; CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:8999868}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=6; CC Name=1; CC IsoId=P31942-1; Sequence=Displayed; CC Name=2; Synonyms=2H9A; CC IsoId=P31942-2; Sequence=VSP_005840; CC Name=3; Synonyms=2H9B; CC IsoId=P31942-3; Sequence=VSP_005838; CC Name=4; Synonyms=2H9C; CC IsoId=P31942-4; Sequence=VSP_005839; CC Name=5; Synonyms=2H9D; CC IsoId=P31942-5; Sequence=VSP_005839, VSP_005843, VSP_005844; CC Name=6; Synonyms=2H9E; CC IsoId=P31942-6; Sequence=VSP_005841, VSP_005842, VSP_005843, CC VSP_005844; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; L32610; AAD45179.1; -; mRNA. DR EMBL; AF132360; AAF68843.1; -; Genomic_DNA. DR EMBL; AF132360; AAF68844.1; -; Genomic_DNA. DR EMBL; AF132360; AAF68845.1; -; Genomic_DNA. DR EMBL; AF132360; AAF68846.1; -; Genomic_DNA. DR EMBL; AF132360; AAF68847.1; -; Genomic_DNA. DR EMBL; AF132360; AAF68848.1; -; Genomic_DNA. DR EMBL; AF132361; AAF68849.1; -; mRNA. DR EMBL; AF132362; AAF68850.1; -; mRNA. DR EMBL; AF132363; AAF68851.1; -; mRNA. DR EMBL; AF132364; AAF68852.1; -; mRNA. DR EMBL; AK091411; BAG52353.1; -; mRNA. DR EMBL; AK291547; BAF84236.1; -; mRNA. DR EMBL; AL117395; CAB55897.1; -; mRNA. DR EMBL; CH471083; EAW54281.1; -; Genomic_DNA. DR EMBL; CH471083; EAW54282.1; -; Genomic_DNA. DR EMBL; BC004511; AAH04511.2; -; mRNA. DR EMBL; BC039824; AAH39824.1; -; mRNA. DR CCDS; CCDS7278.1; -. [P31942-1] DR CCDS; CCDS7279.1; -. [P31942-2] DR PIR; T17207; T17207. DR RefSeq; NP_001309363.1; NM_001322434.1. [P31942-1] DR RefSeq; NP_001309365.1; NM_001322436.1. [P31942-1] DR RefSeq; NP_001309366.1; NM_001322437.1. [P31942-1] DR RefSeq; NP_001309367.1; NM_001322438.1. [P31942-2] DR RefSeq; NP_001309368.1; NM_001322439.1. [P31942-2] DR RefSeq; NP_001309369.1; NM_001322440.1. [P31942-2] DR RefSeq; NP_001309370.1; NM_001322441.1. [P31942-2] DR RefSeq; NP_001309374.1; NM_001322445.1. [P31942-4] DR RefSeq; NP_001309375.1; NM_001322446.1. [P31942-4] DR RefSeq; NP_001309376.1; NM_001322447.1. [P31942-4] DR RefSeq; NP_001309377.1; NM_001322448.1. [P31942-4] DR RefSeq; NP_001309378.1; NM_001322449.1. [P31942-4] DR RefSeq; NP_036339.1; NM_012207.2. [P31942-1] DR RefSeq; NP_067676.2; NM_021644.3. [P31942-2] DR RefSeq; XP_016871657.1; XM_017016168.1. DR RefSeq; XP_016871658.1; XM_017016169.1. DR SMR; P31942; -. DR BioGRID; 109430; 210. DR IntAct; P31942; 92. DR MINT; P31942; -. DR STRING; 9606.ENSP00000265866; -. DR DrugBank; DB09130; Copper. DR iPTMnet; P31942; -. DR MetOSite; P31942; -. DR PhosphoSitePlus; P31942; -. DR SwissPalm; P31942; -. DR BioMuta; HNRNPH3; -. DR DMDM; 23503095; -. DR EPD; P31942; -. DR jPOST; P31942; -. DR MassIVE; P31942; -. DR MaxQB; P31942; -. DR PaxDb; P31942; -. DR PeptideAtlas; P31942; -. DR PRIDE; P31942; -. DR ProteomicsDB; 54808; -. [P31942-1] DR ProteomicsDB; 54809; -. [P31942-2] DR ProteomicsDB; 54810; -. [P31942-3] DR ProteomicsDB; 54811; -. [P31942-4] DR ProteomicsDB; 54812; -. [P31942-5] DR ProteomicsDB; 54813; -. [P31942-6] DR TopDownProteomics; P31942-1; -. [P31942-1] DR TopDownProteomics; P31942-2; -. [P31942-2] DR Antibodypedia; 14612; 98 antibodies. DR Ensembl; ENST00000265866; ENSP00000265866; ENSG00000096746. [P31942-1] DR Ensembl; ENST00000354695; ENSP00000346726; ENSG00000096746. [P31942-2] DR GeneID; 3189; -. DR KEGG; hsa:3189; -. DR UCSC; uc001jnw.5; human. [P31942-1] DR CTD; 3189; -. DR DisGeNET; 3189; -. DR EuPathDB; HostDB:ENSG00000096746.17; -. DR GeneCards; HNRNPH3; -. DR HGNC; HGNC:5043; HNRNPH3. DR HPA; ENSG00000096746; Low tissue specificity. DR MIM; 602324; gene. DR neXtProt; NX_P31942; -. DR OpenTargets; ENSG00000096746; -. DR PharmGKB; PA162391325; -. DR eggNOG; KOG4211; Eukaryota. DR GeneTree; ENSGT00940000157720; -. DR HOGENOM; CLU_032003_1_0_1; -. DR InParanoid; P31942; -. DR OMA; YGNEGFD; -. DR PhylomeDB; P31942; -. DR TreeFam; TF316157; -. DR PathwayCommons; P31942; -. DR BioGRID-ORCS; 3189; 28 hits in 855 CRISPR screens. DR ChiTaRS; HNRNPH3; human. DR GeneWiki; HNRPH3; -. DR GenomeRNAi; 3189; -. DR Pharos; P31942; Tbio. DR PRO; PR:P31942; -. DR Proteomes; UP000005640; Chromosome 10. DR RNAct; P31942; protein. DR Bgee; ENSG00000096746; Expressed in tendon of biceps brachii and 246 other tissues. DR ExpressionAtlas; P31942; baseline and differential. DR Genevisible; P31942; HS. DR GO; GO:0005654; C:nucleoplasm; IDA:HPA. DR GO; GO:0005634; C:nucleus; IDA:UniProtKB. DR GO; GO:1990904; C:ribonucleoprotein complex; IBA:GO_Central. DR GO; GO:0005681; C:spliceosomal complex; TAS:UniProtKB. DR GO; GO:0003723; F:RNA binding; HDA:UniProtKB. DR GO; GO:0030855; P:epithelial cell differentiation; IEP:UniProtKB. DR GO; GO:0000398; P:mRNA splicing, via spliceosome; NAS:UniProtKB. DR GO; GO:0043484; P:regulation of RNA splicing; IBA:GO_Central. DR GO; GO:0006396; P:RNA processing; TAS:ProtInc. DR GO; GO:0008380; P:RNA splicing; TAS:ProtInc. DR CDD; cd12732; RRM2_hnRNPH3; 1. DR CDD; cd12735; RRM3_hnRNPH3; 1. DR Gene3D; 3.30.70.330; -; 2. DR InterPro; IPR034970; hnRNPH3_RRM2. DR InterPro; IPR034969; hnRNPH3_RRM3. DR InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf. DR InterPro; IPR035979; RBD_domain_sf. DR InterPro; IPR000504; RRM_dom. DR Pfam; PF00076; RRM_1; 2. DR SMART; SM00360; RRM; 2. DR SUPFAM; SSF54928; SSF54928; 2. DR PROSITE; PS50102; RRM; 2. PE 1: Evidence at protein level; KW Acetylation; Alternative splicing; Direct protein sequencing; KW Isopeptide bond; Methylation; mRNA processing; Nucleus; Phosphoprotein; KW Polymorphism; Reference proteome; Repeat; Ribonucleoprotein; RNA-binding; KW Ubl conjugation. FT CHAIN 1..346 FT /note="Heterogeneous nuclear ribonucleoprotein H3" FT /id="PRO_0000081861" FT DOMAIN 16..93 FT /note="RRM 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00176" FT DOMAIN 195..270 FT /note="RRM 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00176" FT COMPBIAS 108..344 FT /note="Gly-rich" FT MOD_RES 1 FT /note="N-acetylmethionine" FT /evidence="ECO:0000269|Ref.7" FT MOD_RES 121 FT /note="Asymmetric dimethylarginine" FT /evidence="ECO:0000269|PubMed:11152131" FT MOD_RES 174 FT /note="Omega-N-methylarginine" FT /evidence="ECO:0000244|PubMed:24129315" FT MOD_RES 216 FT /note="Phosphoserine" FT /evidence="ECO:0000244|PubMed:17081983, FT ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:18691976, FT ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:19690332, FT ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, FT ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569" FT MOD_RES 287 FT /note="Omega-N-methylarginine" FT /evidence="ECO:0000269|Ref.7" FT MOD_RES 296 FT /note="Phosphotyrosine" FT /evidence="ECO:0000244|PubMed:24275569" FT MOD_RES 298 FT /note="Phosphoserine" FT /evidence="ECO:0000244|PubMed:19690332, FT ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692, FT ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569" FT MOD_RES 314 FT /note="Phosphothreonine" FT /evidence="ECO:0000244|PubMed:19690332, FT ECO:0000244|PubMed:23186163" FT MOD_RES 323 FT /note="Omega-N-methylarginine" FT /evidence="ECO:0000244|PubMed:24129315" FT MOD_RES 343 FT /note="Omega-N-methylarginine" FT /evidence="ECO:0000244|PubMed:24129315" FT CROSSLNK 6 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO2)" FT /evidence="ECO:0000244|PubMed:28112733" FT CROSSLNK 67 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO2)" FT /evidence="ECO:0000244|PubMed:28112733" FT VAR_SEQ 1..137 FT /note="Missing (in isoform 6)" FT /evidence="ECO:0000303|PubMed:10858537" FT /id="VSP_005841" FT VAR_SEQ 1..131 FT /note="Missing (in isoform 4 and isoform 5)" FT /evidence="ECO:0000303|PubMed:10858537, FT ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:17974005" FT /id="VSP_005839" FT VAR_SEQ 1..49 FT /note="Missing (in isoform 3)" FT /evidence="ECO:0000303|PubMed:10858537" FT /id="VSP_005838" FT VAR_SEQ 132..146 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:10858537, FT ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334" FT /id="VSP_005840" FT VAR_SEQ 138..145 FT /note="RGGDGYDG -> MCFSLNYT (in isoform 6)" FT /evidence="ECO:0000303|PubMed:10858537" FT /id="VSP_005842" FT VAR_SEQ 259..276 FT /note="QHRYIELFLNSTPGGGSG -> RKWCLWHTILFPKREFIK (in isoform FT 5 and isoform 6)" FT /evidence="ECO:0000303|PubMed:10858537" FT /id="VSP_005843" FT VAR_SEQ 277..346 FT /note="Missing (in isoform 5 and isoform 6)" FT /evidence="ECO:0000303|PubMed:10858537" FT /id="VSP_005844" FT VARIANT 163 FT /note="N -> S (in dbSNP:rs2273903)" FT /id="VAR_020333" FT VARIANT 284 FT /note="G -> A (in dbSNP:rs16925347)" FT /id="VAR_052226" FT MOD_RES P31942-2:116 FT /note="Omega-N-methylarginine" FT /evidence="ECO:0000244|PubMed:24129315" FT MOD_RES P31942-2:121 FT /note="Omega-N-methylarginine" FT /evidence="ECO:0000244|PubMed:24129315" FT MOD_RES P31942-2:129 FT /note="Omega-N-methylarginine" FT /evidence="ECO:0000244|PubMed:24129315" SQ SEQUENCE 346 AA; 36926 MW; F7D14C2947930E9E CRC64; MDWVMKHNGP NDASDGTVRL RGLPFGCSKE EIVQFFQGLE IVPNGITLTM DYQGRSTGEA FVQFASKEIA ENALGKHKER IGHRYIEIFR SSRSEIKGFY DPPRRLLGQR PGPYDRPIGG RGGYYGAGRG SMYDRMRRGG DGYDGGYGGF DDYGGYNNYG YGNDGFDDRM RDGRGMGGHG YGGAGDASSG FHGGHFVHMR GLPFRATEND IANFFSPLNP IRVHIDIGAD GRATGEADVE FVTHEDAVAA MSKDKNNMQH RYIELFLNST PGGGSGMGGS GMGGYGRDGM DNQGGYGSVG RMGMGNNYSG GYGTPDGLGG YGRGGGGSGG YYGQGGMSGG GWRGMY //